PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
批准号:
10700965
负责人:
Aaron Grossberg
金额:
$42.41万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-10 至 2026-08-31
关键词:
AcuteAdipose tissueAdrenergic AgentsAdrenergic ReceptorAnimalsAnorexiaAtrophicAttenuatedBehaviorBehavioralBody Weight decreasedCachexiaCancer PatientCardiacCardiovascular systemCatabolismChronicChronic DiseaseChronic stressClinical Trials DesignCollaborationsCorticosteroneCorticotropin-Releasing HormoneDataDedicationsDiseaseEnergy MetabolismEvolutionExhibitsFatigueFunctional disorderGeneticGlucocorticoidsGoalsHumanHypothalamic structureImpairmentInflammatoryInterventionLaboratoriesLethargiesLifeMalignant NeoplasmsMetabolicMetabolic dysfunctionMetabolic syndromeMetabolismModelingMorbidity - disease rateMotivationMusMuscleMuscular AtrophyNerveNeuroendocrinologyNeuronsNeurosecretory SystemsNeurotransmittersNorepinephrineObservational StudyOrganOrganismOutputPancreatic Ductal AdenocarcinomaPathologicPathway interactionsPatientsPeripheralPharmaceutical PreparationsPharmacologic SubstancePhase II Clinical TrialsPhenotypePhysical FunctionPhysiologicalPlasmaPre-Clinical ModelPreventionQuality of lifeReagentResearchRoleSick RoleSignal TransductionSkeletal MuscleStressSympathetic Nervous SystemSystemic diseaseTestingTherapeuticTherapeutic InterventionTissuesacute stressbehavioral phenotypingbehavioral responsebiological adaptation to stresscancer cachexiacancer typeclinical translationdefined contributiondensitydesignexercise intoleranceexperiencefunctional declinehypothalamic-pituitary-adrenal axismetabolic phenotypemortality riskmouse modelneuroinflammationnew therapeutic targetnovelnovel therapeuticspancreatic cancer patientspancreatic ductal adenocarcinoma modelpharmacologicprospectiveresponsesynergismsystemic inflammatory responsetherapeutically effectivetumortumor growthwasting
中文摘要
项目总结:
英文摘要
Project Summary:
Illness behaviors, metabolic disturbances, and cardiovascular compromise are common in patients with
chronic systemic diseases, and contribute substantially to quality of life and ultimate survival. Other illness-
induced morbidities including anorexia and lethargy also compromise the ability of patients to recover from life-
saving or extending interventions, and diminish the motivational drive to aggressively battle the underlying
condition. Although cachexia in cancer patients was described more than two thousand years ago, the central
mechanisms underlying this disorder are poorly understood. Furthermore, there is currently no effective
pharmaceutical treatment. Cardiovascular impairment is common in all chronic diseases, and can be a
presenting complaint in cancer patients, even prior to initiation of therapy. Our laboratory is dedicated to
unraveling the basic mechanisms whereby cancer triggers neuroinflammation and subsequent chronic
activation of systemic stress responses in patients with cancer. In this proposal, we will focus on understanding
the scope and mechanism by which systemic illness induces chronic activation and alteration in the
sympathetic nervous system. The significance of this proposal resides in its unique combination of our
historical focus on neuroendocrinology and neuroinflammation, with new collaborations and efforts directed at
understanding the extent and mechanisms of cardiovascular impairment and sympathetic nervous system
plasticity in patients with cancer. The long-term goal of our research is to gain mechanistic understanding of
the acute illness response and how it is transitioned into chronic neuroinflammation in all cancer types, in order
to develop more effective therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
-
批准号:10801439
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2023
-
负责人:Aaron Grossberg
-
依托单位:
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
-
批准号:10210248
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2020
-
负责人:Aaron Grossberg
-
依托单位:
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
-
批准号:10435494
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2020
-
负责人:Aaron Grossberg
-
依托单位:
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
-
批准号:10054796
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2020
-
负责人:Aaron Grossberg
-
依托单位:
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
-
批准号:10668391
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2020
-
负责人:Aaron Grossberg
-
依托单位:
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.
-
批准号:8114025
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2009
-
负责人:Aaron Grossberg
-
依托单位:
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.
-
批准号:8318225
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2009
-
负责人:Aaron Grossberg
-
依托单位:
Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.
-
批准号:7750905
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2009
-
负责人:Aaron Grossberg
-
依托单位:
海外基金